Teva CEO Discusses Q2 Earnings and NYSE Direct Listing
Earnings·1 article across 1 outlet
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Teva Pharmaceuticals CEO Richard Francis spoke about the company's positive Q2 earnings during an interview with Bloomberg. He also addressed the impending impact of changing Medicare rules on patients and the new listing on the NYSE.
The discussion highlighted the significance of the direct listing for Teva, as well as the potential effects of Medicare changes on their business operations and patient care.
Teva PharmaceuticalsRichard Francis
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“Teva Pharmaceuticals CEO Richard Francis speaks to Bloomberg's Romaine Bostick about the company's positive Q2 earnings, the impending impact of changing Medicare rules on patients, and the new listing on the NYSE.”
Bloomberg — Teva CEO on Drug Pipeline, Direct Listing on NYSE